Current Drug Metabolism logo Bentham Science Publishers logo

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.

Publisher: Bentham Science Publishers

Volume 8, Number 3, April 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
pp. 197-200(4)
Author: Murray, Michael F.

Indoleamine 2,3-Dioxygenase in Materno-Fetal Interaction
pp. 205-208(4)
Author: Sedlmayr, Peter

Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells
pp. 209-216(8)
Authors: Fallarino, Francesca; Gizzi, S.; Mosci, P.; Grohmann, U.; Puccetti, P.

How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
pp. 217-223(7)
Authors: Boasso, Adriano; Shearer, Gene M.

Indoleamine-2, 3-Dioxygenase and Other Interferon-γ-Mediated Pathways in Patients with Human Immunodeficiency Virus Infection
pp. 225-236(12)
Authors: Schroecksnadel, Katharina; Zangerle, R.; Bellmann-Weiler, R.; Garimorth, K.; Weiss, G.; Fuchs, Dietmer

Indoleamine 2,3-Dioxygenase in Hematopoietic Stem Cell Transplantation
pp. 267-272(6)
Authors: Hainz, U.; Jurgens, B.; Wekerle, T.; Seidel, M. G.; Heitger, Andreas

Implications of IFN-γ-Mediated Tryptophan Catabolism on Solid Organ Transplantation
pp. 273-282(10)
Authors: Brandacher, Gerald; Margreiter, Raimund; Fuchs, Dietmer

IDO and Clinical Conditions Associated with Depressive Symptoms
pp. 283-287(5)
Authors: Kohl, Claudia; Sperner-Unterweger, B.

Chronic Immune Activation Underlies Morbid Obesity: Is IDO A Key Player?
pp. 289-295(7)
Authors: Brandacher, G.; Hoeller, E.; Fuchs, D.; Weiss, Helmut G.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A